We are live on ! Find out more
BLU

BELLUS Health Inc.

Delisted

BLU was delisted on the 28th of June, 2023.

50 hedge funds and large institutions have $52.8M invested in BELLUS Health Inc. in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 11

22% less funds holding

Funds holding: 6450 (-14)

52% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 27

86% less capital invested

Capital invested by funds: $376M → $52.8M (-$324M)

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
50
Holders Change
-14
Holders Change %
-21.88%
% of All Funds
1.01%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
13
Increased
12
Reduced
11
Closed
27
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$11.7M
RI
2
RTW Investments
New York
$9.55M -$5.03M -1,774,874 -30%
PC
3
Polar Capital
United Kingdom
$6.81M +$6.38M +2,250,000 +300%
BC
4
Boxer Capital
California
$6.75M +$3.4M +1,200,000 +68%
FM
5
Frazier Management
Washington
$2.96M +$3.68M +1,296,743 New
Morgan Stanley
6
Morgan Stanley
New York
$2.73M +$1.24M +438,077 +57%
Citadel Advisors
7
Citadel Advisors
Florida
$2.16M +$689K +243,165 +35%
SM
8
Sabby Management
Florida
$2M +$2.5M +880,400 New
First Manhattan
9
First Manhattan
New York
$1.99M
MWNA
10
Marshall Wace North America
New York
$1.41M -$2.46M -867,782 -58%
AG
11
Artal Group
Luxembourg
$1.08M +$939K +331,237 +230%
Arrowstreet Capital
12
Arrowstreet Capital
Massachusetts
$721K +$901K +317,700 New
SCM
13
Suvretta Capital Management
New York
$547K
Ameriprise
14
Ameriprise
Minnesota
$296K +$369K +130,300 New
KPF
15
K2 Principal Fund
Ontario, Canada
$264K +$330K +116,470 New
Goldman Sachs
16
Goldman Sachs
New York
$228K +$177K +62,517 +165%
IC
17
Ikarian Capital
Texas
$227K +$284K +100,000 New
Swiss National Bank
18
Swiss National Bank
Switzerland
$218K +$25.2K +8,900 +10%
FWSM
19
First Wilshire Securities Management
California
$186K +$232K +82,000 New
Deutsche Bank
20
Deutsche Bank
Germany
$181K -$17.3K -6,114 -7%
WMSA
21
Weiss Multi-Strategy Advisers
New York
$80K -$27.9K -9,837 -22%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$78K
TD Asset Management
23
TD Asset Management
Ontario, Canada
$76K -$89.3K -31,513 -49%
UBS AM
24
UBS AM
Illinois
$70.8K
Vanguard Group
25
Vanguard Group
Pennsylvania
$57K

BLU Hedge Fund Activity: Q3 2020 in Review

50 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q3 2020, worth a combined $52.8M — down 86% from $376M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of BLU and 13 opened new positions — a net loss of 14 holders — while 11 trimmed existing stakes and 12 added.

The largest buyer was Polar Capital, adding an estimated $6.38M. The largest seller was Fidelity Investments, exiting entirely with an estimated $46.5M sold.

  • 50 institutional investors held BELLUS Health Inc. (BLU) as of Q3 2020, down from 64 in Q2 2020.
  • Funds reported $52.8M of BELLUS Health Inc. stock for Q3 2020, down 86% quarter-over-quarter.
  • 13 funds opened new BELLUS Health Inc. positions in Q3 2020 and 27 closed out, a net change of -14 holders.
  • The largest BELLUS Health Inc. buyer in Q3 2020 was Polar Capital, an estimated $6.38M added.
  • The largest BELLUS Health Inc. seller in Q3 2020 was Fidelity Investments, an estimated $46.5M sold.

Based on aggregated 13F filings for Q3 2020.